Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1974 Jan;50(579):16–24. doi: 10.1136/pgmj.50.579.16

Treatment of active chronic hepatitis with cyclophosphamide

R Naccarato, M Chiaramonte, R Farini, U Fagiolo, G C Sturniolo
PMCID: PMC2495510  PMID: 4464495

Abstract

Twenty patients with active chronic hepatitis, classified on the basis of the treatment into three groups, have been studied: (1) patients treated with cyclophosphamide (10 patients); (2) patients treated with cyclophosphamide after cycles of corticosteroid therapy (four patients); (3) patients treated with corticosteroid (six patients).

In all patients we observed clinical, biochemical and immunological changes during and after treatment.

Hepatic needle-biopsy was performed in all patients before treatment. The histological picture was rechecked after the first cycle of therapy in twelve patients.

The results obtained in the three groups of patients have been statistically compared.

Cyclophosphamide treatment produces an improvement of general conditions and a persistent normalization of several biochemical and immunological data, especially in those patients in which active chronic hepatitis was not in an advanced stage (type A aggressive form). The histological picture showed no changes after treatment.

Full text

PDF
16

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alepa F. P., Zvaifler N. J., Sliwinski A. J. Immunologic effects of cyclophosphamide treatment in rheumatoid arthritis. Arthritis Rheum. 1970 Nov-Dec;13(6):754–760. doi: 10.1002/art.1780130604. [DOI] [PubMed] [Google Scholar]
  2. BROCK N., HOHORST H. J. UBER DIE AKTIVIERUNG VON CYCLOPHOSPHAMID IN VIVO UND IN VITRO. Arzneimittelforschung. 1963 Dec;13:1021–1031. [PubMed] [Google Scholar]
  3. Bedarida G., Trinchieri G., Carbonara A. The detection of Australia antigen and anti-Au antibodies by a rapid procedure combining electrophoresis and immunoprecipitation. Haematologica. 1969;54(9):591–602. [PubMed] [Google Scholar]
  4. Booth L. J., Aber G. M. Immunosuppressive therapy in adults with proliferative glomerulonephritis. Controlled trial. Lancet. 1970 Nov 14;2(7681):1010–1013. doi: 10.1016/s0140-6736(70)92817-5. [DOI] [PubMed] [Google Scholar]
  5. COONS A. H., KAPLAN M. H. Localization of antigen in tissue cells; improvements in a method for the detection of antigen by means of fluorescent antibody. J Exp Med. 1950 Jan 1;91(1):1–13. doi: 10.1084/jem.91.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. COWLING D. C., MACKAY I. R., TAFT L. I. Lupoid hepatitis. Lancet. 1956 Dec 29;271(6957):1323–1326. doi: 10.1016/s0140-6736(56)91483-0. [DOI] [PubMed] [Google Scholar]
  7. Cook G. C., Mulligan R., Sherlock S. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med. 1971 Apr;40(158):159–185. doi: 10.1093/oxfordjournals.qjmed.a067264. [DOI] [PubMed] [Google Scholar]
  8. Fairley K. F., Barrie J. U., Johnson W. Sterility and testicular atrophy related to cyclophosphamide therapy. Lancet. 1972 Mar 11;1(7750):568–569. doi: 10.1016/s0140-6736(72)90358-3. [DOI] [PubMed] [Google Scholar]
  9. Grushkin C. M., Fine R. N., Heuser E., Lieberman E. Cyclophosphamide therapy of idiopathic nephrosis. Calif Med. 1970 Dec;113(6):1–5. [PMC free article] [PubMed] [Google Scholar]
  10. Krawitt E. L., Stein J. H., Kirkendall W. M., Clifton J. A. Mercaptopurine hepatotoxicity in a patient with chronic active hepatitis. Arch Intern Med. 1967 Dec;120(6):729–734. [PubMed] [Google Scholar]
  11. Lavin P., Koss L. G. Effects of a single dose of cyclophosphamide on various organs in the rat. 3. Electron microscopic study of the liver. Am J Pathol. 1971 Feb;62(2):159–168. [PMC free article] [PubMed] [Google Scholar]
  12. MACKAY I. R., WEIDEN S., UNGAR B. TREATMENT OF ACTIVE CHRONIC HEPATITIS AND LUPOID HEPATITIS WITH 6-MERCAPTOPURINE AND AZOTHIOPRINE. Lancet. 1964 Apr 25;1(7339):899–902. doi: 10.1016/s0140-6736(64)91627-7. [DOI] [PubMed] [Google Scholar]
  13. Mackay I. R., Weiden S., Hasker J. Autoimmune hepatitis. Ann N Y Acad Sci. 1965 Jun 30;124(2):767–780. doi: 10.1111/j.1749-6632.1965.tb19000.x. [DOI] [PubMed] [Google Scholar]
  14. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  15. Mistilis S. P., Blackburn C. R. The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine. Australas Ann Med. 1967 Nov;16(4):305–311. doi: 10.1111/imj.1967.16.4.305. [DOI] [PubMed] [Google Scholar]
  16. Nakamura R. M., Weigle W. O. Suppression of thyroid lesions in rabbits by treatment with cyclophosphamide after the induction of thyroiditis. Clin Exp Immunol. 1970 Oct;7(4):541–550. [PMC free article] [PubMed] [Google Scholar]
  17. PAGE A. R., CONDIE R. M., GOOD R. A. SUPPRESSION OF PLASMA CELL HEPATITIS WITH 6-MERCAPTOPURINE. Am J Med. 1964 Feb;36:200–213. doi: 10.1016/0002-9343(64)90083-x. [DOI] [PubMed] [Google Scholar]
  18. Paterson P. Y., Drobish D. G., Biddick A. S. Cyclosphosphamide inhibition of experimental allergic thyroiditis and thyroid antibody production in rats. J Immunol. 1971 Feb;106(2):570–572. [PubMed] [Google Scholar]
  19. Popper H., Paronetto F., Schaffner F. Immune processes in the pathogenesis of liver disease. Ann N Y Acad Sci. 1965 Jun 30;124(2):781–799. doi: 10.1111/j.1749-6632.1965.tb19001.x. [DOI] [PubMed] [Google Scholar]
  20. Santos G. W. Symposium on immunosuppressive drugs. Immunosuppressive drugs. I. Fed Proc. 1967 May-Jun;26(3):907–913. [PubMed] [Google Scholar]
  21. Shulman N. R., Barker L. F. Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science. 1969 Jul 18;165(3890):304–306. doi: 10.1126/science.165.3890.304. [DOI] [PubMed] [Google Scholar]
  22. Steinberg A. D., Kaltreider H. B., Staples P. J., Goetzl E. J., Talal N., Decker J. L. Cyclophosphamide in lupus nephritis: a controlled trial. Ann Intern Med. 1971 Aug;75(2):165–171. doi: 10.7326/0003-4819-75-2-165. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES